Skip to main content
. 2022 Jan 11;13(1):1359–1376. doi: 10.1080/21655979.2021.2017588

Figure 7.

Figure 7.

PI3K and NF-κB inhibition impaired the lncRNA PURPL-mediated cancer-promoting function The PI3K inhibitor LY294002 (Cat.No: HY-10108) (10 μM) and the NF-κB inhibitor JSH-23 (Cat.No: HY-13982) (30 μM) were administered to the AGS model with PURPL overexpression, respectively. A. Colony formation assay examined cell proliferation in each group. B. Transwell analyzed cell migration and invasion. C. Flow cytometry determined the apoptosis rate of AGS cells. D. Western blot confirmed the profiles of apoptosis-concerned cells Bax, Bcl2, and Caspase3. E. Western blot verified the protein profile of the PI3K/AKT/NF-κB pathway. **P < 0.01, ***, P < 0.001 (vs. the vec group), # P < 0.05, ## P < 0.01, ### P < 0.001 (vs. the PURPL group), N = 3.